Safety and Efficacy of Prasugrel Administration in Emergent Endovascular Treatment for Intracranial Atherosclerotic Disease

CONCLUSION: Prasugrel administration was significantly associated with target vessel patency and good clinical outcome after emergent EVT for ICAD without increasing the symptomatic ICH rate. Prasugrel administration might be safe and effective to avoid reocclusion during and after emergent EVT for ICAD.PMID:37546344 | PMC:PMC10400910 | DOI:10.5797/jnet.oa.2023-0008
Source: Atherosclerosis - Category: Cardiology Authors: Source Type: research